What is the most appropriate initial nursing intervention for a patient newly diagnosed with active tuberculosis?

B) Educate the patient on the importance of adhering to the prescribed medication regimen.

A) Encourage the patient to increase fluid intake to prevent dehydration.

B) Educate the patient on the importance of adhering to the prescribed medication regimen.

C) Advise the patient to avoid physical activity to conserve energy.

D) Recommend the patient wear a mask at all times to prevent transmission.

A 28-year-old female patient with newly diagnosed tuberculosis has been prescribed isoniazid, rifampin, pyrazinamide, and ethambutol. Which of the following is an essential nursing intervention when administering these medications?

B) Monitor the patient for signs of liver toxicity, such as jaundice.

A) Encourage the patient to increase fluid intake to prevent dehydration.

B) Monitor the patient for signs of liver toxicity, such as jaundice.

C) Instruct the patient to avoid dairy products to enhance medication absorption.

D) Assess the patient's blood glucose levels regularly.

During a follow-up visit, a patient with tuberculosis reports an improvement in symptoms and a reduction in night sweats. What is the most important reason the nurse should continue to emphasize the completion of the full course of anti-tubercular therapy?

D) To avoid the development of drug resistance

A) To prevent the recurrence of tuberculosis symptoms

B) To ensure the development of immunity against tuberculosis

C) To reduce the risk of transmitting tuberculosis to others

D) To avoid the development of drug resistance

What is the most appropriate initial nursing action when a patient undergoing anti-tubercular therapy reports a reduction in night sweats and fatigue?

C) Reinforce the importance of completing the full course of therapy.

A) Increase the patient's medication dosage.

B) Encourage the patient to reduce her medication adherence.

C) Reinforce the importance of completing the full course of therapy.

D) Discontinue the patient's current treatment plan.

Which of the following actions should the nurse prioritize for a patient on anti-tubercular therapy who presents with mild elevation in liver enzymes?

B) Monitor liver function tests regularly

A) Increase fluid intake to flush out the liver

B) Monitor liver function tests regularly

C) Discontinue the current medication regimen

D) Recommend a high-protein diet to support liver health

A patient is experiencing mild joint pain and tingling in her hands, and lab results show elevated liver enzymes. Which dietary recommendation should the nurse prioritize to support liver health?

A) Increase intake of leafy green vegetables

C) Drink more caffeinated beverages

D) Avoid all sources of dietary fat

During a follow-up appointment, a patient reports mild joint pain and tingling in her hands, and her lab results show slight elevations in liver enzymes. Which dietary recommendation is most appropriate to support liver health?

B) Consume foods rich in antioxidants

A) Increase intake of fried foods

B) Consume foods rich in antioxidants

C) Drink caffeinated beverages frequently

Tb - Nursing Case Study

Pathophysiology

• Primary mechanism: Inhalation of Mycobacterium tuberculosis leads to infection in the lungs, where the bacteria are engulfed by macrophages. Instead of being destroyed, the bacteria survive within these cells, creating a local immune response and forming granulomas (tubercles) to contain the infection.

• Secondary mechanism: The immune system mounts a cell-mediated response, involving T-cells, to control the infection. However, if the immune response is insufficient or compromised, the bacteria can multiply and spread, leading to active disease and lung tissue damage.

• Key complication: If granulomas break down, it may result in cavitation and tissue necrosis, leading to symptoms like persistent cough and hemoptysis (coughing up blood), and allowing the bacteria to spread to others.

Patient Profile

Demographics:

28-year-old female, school teacher

History:

• Key past medical history: No significant past medical history

• Current medications: None

• Allergies: No known drug allergies

Current Presentation:

• Chief complaint: Persistent cough for the past three weeks

• Key symptoms: Mild fever, night sweats, fatigue, loss of appetite

• Vital signs: Temperature 37.5°C, Heart rate 78 bpm, Blood pressure 118/76 mmHg, Respiratory rate 18 breaths/min, SpO2 98% on room air

Section 1

Initial assessment findings reveal that the patient, a 28-year-old female school teacher, appears generally well but exhibits signs consistent with early-stage tuberculosis. On physical examination, auscultation of the lungs reveals faint crackles over the right upper lobe, suggesting localized lung involvement. There are no signs of respiratory distress, as indicated by a respiratory rate of 18 breaths per minute and an SpO2 of 98% on room air. The patient's skin is warm to touch, correlating with her mild fever of 37.5°C. She reports night sweats and fatigue, contributing to her sense of general malaise and loss of appetite.

Further diagnostic workup is initiated, including a chest X-ray and a sputum culture. The chest X-ray shows a small area of opacity in the right upper lobe, consistent with the presence of a granuloma. This finding aligns with the early containment of the infection by the immune system. The sputum culture is pending, but preliminary results from an acid-fast bacilli (AFB) smear are positive, providing strong evidence for active tuberculosis infection. Basic blood work reveals mild anemia, likely secondary to chronic inflammation, with a hemoglobin level of 11.5 g/dL, which could explain her fatigue.

These findings validate the suspicion of tuberculosis and underscore the need for straightforward, yet effective interventions. The patient is counseled on the importance of starting a standard anti-tubercular therapy regimen, which typically includes isoniazid, rifampin, pyrazinamide, and ethambutol. Education on medication adherence, potential side effects, and the importance of follow-up appointments is emphasized to ensure successful treatment outcomes and prevent potential complications, such as cavitation or disease progression. The nursing team will monitor the patient's response to therapy, focusing on symptom resolution and any emerging side effects.

Section 2

Two weeks into the anti-tubercular therapy, the patient returns for a follow-up appointment. During her visit, she reports a noticeable improvement in her symptoms. Her night sweats have significantly reduced, and she feels less fatigued, allowing her to resume some of her usual activities, although she is still taking care to rest adequately. She maintains a positive outlook, expressing confidence in the treatment plan and adhering diligently to the medication regimen. Upon physical examination, her vital signs remain stable, with a respiratory rate of 16 breaths per minute and an SpO2 of 99% on room air. Her temperature is now within normal range at 36.8°C, indicating a reduction in febrile episodes.

The nursing team evaluates her recent laboratory results, which show a slight improvement in her hemoglobin level, now at 12.0 g/dL, suggesting a gradual resolution of her anemia. The sputum culture results confirm the presence of Mycobacterium tuberculosis, reinforcing the diagnosis and ensuring the appropriateness of the current treatment plan. With these encouraging signs, the nursing staff continues to educate the patient on the importance of completing the full course of therapy, discussing the need for regular monitoring to prevent any potential complications such as drug-induced hepatitis.

In preparation for her next phase of care, the patient is scheduled for monthly follow-ups to track her progress and monitor for any adverse effects of the medication, such as hepatotoxicity or visual disturbances from ethambutol. The nursing team also reinforces infection control measures to prevent transmission, advising her on maintaining proper hygiene and the importance of reporting any new symptoms promptly. As she leaves the clinic, the patient expresses her gratitude for the support and guidance she has received, feeling optimistic about her recovery journey.

Section 3

As the patient progresses into her third month of treatment, she attends her scheduled follow-up appointment. During the visit, she reports a notable decrease in her cough and a return to her normal appetite, which has led to a slight weight gain of 2 kilograms since her last visit. She has been diligent in adhering to the medication regimen, and her positive attitude persists, although she mentions experiencing occasional mild joint pain and intermittent tingling in her hands.

The nursing team conducts a thorough assessment, noting that her vital signs remain stable with a blood pressure of 118/72 mmHg, a heart rate of 72 beats per minute, and an SpO2 of 98% on room air. Her liver function tests, however, reveal a mild elevation in liver enzymes, with an ALT of 65 U/L and an AST of 58 U/L. These findings suggest a potential early sign of hepatotoxicity, a known side effect of anti-tubercular therapy. The team is vigilant, considering this information while continuing to monitor her closely for any signs of worsening liver function.

In response to these findings, the nursing staff consults with the physician to evaluate the need for any adjustments in her medication regimen. They also emphasize the importance of the patient reporting any symptoms such as jaundice or dark urine, which could indicate more significant liver involvement. The patient is reassured that her current symptoms are being actively managed and that regular monitoring is key to ensuring her safety. The nursing team reinforces the importance of maintaining a balanced diet and adequate hydration to support liver health, as they prepare her for the next steps in her treatment journey.

Section 4

During the next scheduled follow-up appointment, approximately one month later, the patient reports feeling generally well, with a continued improvement in her respiratory symptoms and sustained appetite. However, she mentions that the mild joint pain and tingling in her hands have become slightly more frequent, occurring a few times a week. The nursing team performs a comprehensive assessment, which reveals stable vital signs: her blood pressure is 120/74 mmHg, heart rate is 70 beats per minute, and SpO2 remains at 98% on room air. Her weight has increased by another kilogram, indicating ongoing nutritional improvement.

Lab results from this visit show a slight worsening in her liver function tests, with an ALT of 78 U/L and an AST of 65 U/L. These elevations, though still mild, are concerning for potential progression towards hepatotoxicity. In light of these findings, the nursing team collaborates with the physician to consider the benefits and risks of continuing the current medication regimen versus making adjustments to prevent further liver damage. This collaborative approach underscores the importance of interdisciplinary teamwork in managing complex cases.

The nursing team reinforces the importance of the patient adhering to dietary recommendations, particularly focusing on foods that support liver health, such as those rich in antioxidants. They also educate her on recognizing signs of worsening liver function, such as increased fatigue, jaundice, or changes in urine color, encouraging her to report these symptoms promptly. Additionally, they discuss possible modifications to her medication that the physician may recommend, preparing her for potential changes in her treatment plan. This proactive approach aims to maintain her positive progress while mitigating the risk of further complications, emphasizing patient education and empowerment as key components of her ongoing care.

Section 5

During the next follow-up visit, the patient reports that her joint pain and tingling have persisted but not worsened significantly. She continues to feel generally well, and her respiratory symptoms remain under control. The nursing team conducts another comprehensive assessment and notes that her vital signs are stable: blood pressure is 118/76 mmHg, heart rate is 72 beats per minute, and her SpO2 is 97% on room air. Her weight has increased by an additional kilogram, further indicating good nutritional improvement. However, the patient mentions experiencing occasional nausea over the past week, which she attributes to something she ate but is discussed further during the visit.

The latest lab work reveals a slight increase in liver enzyme levels, with ALT now at 85 U/L and AST at 72 U/L. These changes suggest a gradual worsening of liver function, prompting the healthcare team to reassess the current treatment strategy. The nursing team collaborates with the physician to evaluate the possibility of adjusting the medication regimen to alleviate the burden on the liver while maintaining effective TB management. They discuss options such as reducing the dosage of hepatotoxic medications or introducing liver-supportive therapies.

The patient is counseled on the importance of continuing to monitor her symptoms closely and is reminded of the warning signs of significant liver dysfunction, such as increased nausea, jaundice, or dark urine. The nursing team ensures she understands the rationale behind any potential medication changes and reinforces the importance of adherence to the new regimen. By maintaining open communication and providing clear education, the team aims to empower the patient to take an active role in managing her health, ensuring she remains stable and on track with her TB treatment plan.